International Clinical Trial: Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat Glaucoma

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07209410) titled 'Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat Glaucoma' on Oct. 1.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,

Condition: Glaucoma

Intervention: Drug: Brimonidine Tartrate Ophthalmic 0.025%...

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: October 1, 2025

Target Sample Size: 35

Countries of Re...